These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6368288)

  • 1. Normal insulin sensitivity of the islets of Langerhans in obese subjects with resistance to its glucoregulatory actions.
    Klimes I; Nagulesparan M; Vasquez B; Hidaka H; Unger RH
    Diabetes; 1984 Apr; 33(4):305-10. PubMed ID: 6368288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity.
    Elahi D; Nagulesparan M; Hershcopf RJ; Muller DC; Tobin JD; Blix PM; Rubenstein AH; Unger RH; Andres R
    N Engl J Med; 1982 May; 306(20):1196-202. PubMed ID: 7040963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
    Garvey WT; Revers RR; Kolterman OG; Rubenstein AH; Olefsky JM
    J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity.
    Giugliano D; Cozzolino D; Salvatore T; Torella R; Franchimont P; D'Onofrio F; Lefebvre PJ
    J Clin Endocrinol Metab; 1988 Aug; 67(2):238-44. PubMed ID: 2969000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects.
    Prager R; Wallace P; Olefsky JM
    Diabetes; 1987 May; 36(5):607-11. PubMed ID: 3552793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.
    Bolli G; De Feo P; Perriello G; De Cosmo S; Compagnucci P; Santeusanio F; Brunetti P; Unger RH
    J Clin Invest; 1984 Apr; 73(4):917-22. PubMed ID: 6368593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
    Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG
    Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal alpha-cell up-regulation in obese insulin-resistant adolescents.
    Weiss R; D'Adamo E; Santoro N; Hershkop K; Caprio S
    J Clin Endocrinol Metab; 2011 Jan; 96(1):91-7. PubMed ID: 20843946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.
    Egan JM; Meneilly GS; Habener JF; Elahi D
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3768-73. PubMed ID: 12161508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Starvation enhances the ability of insulin to inhibit its own secretion.
    Brodows RG
    Metabolism; 1985 Jan; 34(1):53-7. PubMed ID: 3880857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antilipolytic action of insulin in obese subjects with resistance to its glucoregulatory action.
    Howard BV; Klimes I; Vasquez B; Brady D; Nagulesparan M; Unger RH
    J Clin Endocrinol Metab; 1984 Mar; 58(3):544-8. PubMed ID: 6363441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity to beta-endorphin as a cause of human obesity.
    Giugliano D; Salvatore T; Cozzolino D; Ceriello A; Torella R; D'Onofrio F
    Metabolism; 1987 Oct; 36(10):974-8. PubMed ID: 2958673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
    Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
    Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.
    Røder ME; Dinesen B; Hartling SG; Houssa P; Vestergaard H; Sodoyez-Goffaux F; Binder C
    Diabetes Care; 1999 Apr; 22(4):609-14. PubMed ID: 10189540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD; Schaeffer L; Shragg P; Kolterman OG
    Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of pancreatic beta-cell function in obese children with acanthosis nigricans].
    Liang XJ; Zhu C; Yan C; Ni GC; Liu ZL; Du ZM; Li M
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):405-7. PubMed ID: 15265420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
    Henry RR; Brechtel G; Griver K
    J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.